MITO END-3: efficacy of avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapy
Titel:
MITO END-3: efficacy of avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapy
Auteur:
Pignata, S. Califano, D. Lorusso, D. Arenare, L. Bartoletti, M. De Giorgi, U. Andreetta, C. Pisano, C. Scambia, G. Lombardi, D. Farolfi, A. Cinieri, S. Passarelli, A. Salutari, V. De Angelis, C. Mignogna, C. Priolo, D. Capoluongo, E.D. Tamberi, S. Scaglione, G.L. Arcangeli, V. De Cecio, R. Scognamiglio, G. Greco, F. Spina, A. Turinetto, M. Russo, D. Carbone, V. Casartelli, C. Schettino, C. Perrone, F.